Oncology Institute (TOI) Competitors $3.13 +0.26 (+9.06%) Closing price 04:00 PM EasternExtended Trading$3.12 -0.01 (-0.32%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. LFMD, FLGT, CSTL, PSNL, INNV, EHAB, SBC, CELC, AUNA, and TALKShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include LifeMD (LFMD), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), Personalis (PSNL), InnovAge (INNV), Enhabit (EHAB), SBC Medical Group (SBC), Celcuity (CELC), Auna (AUNA), and Talkspace (TALK). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors LifeMD Fulgent Genetics Castle Biosciences Personalis InnovAge Enhabit SBC Medical Group Celcuity Auna Talkspace LifeMD (NASDAQ:LFMD) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings. Which has preferable earnings and valuation, LFMD or TOI? LifeMD has higher earnings, but lower revenue than Oncology Institute. LifeMD is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$212.45M2.41-$18.88M-$0.34-33.12Oncology Institute$393.41M0.71-$64.66M-$0.70-4.47 Does the media refer more to LFMD or TOI? In the previous week, LifeMD and LifeMD both had 2 articles in the media. LifeMD's average media sentiment score of 1.68 beat Oncology Institute's score of 1.07 indicating that LifeMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Oncology Institute 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is LFMD or TOI more profitable? LifeMD has a net margin of -4.58% compared to Oncology Institute's net margin of -15.38%. LifeMD's return on equity of 0.00% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets LifeMD-4.58% N/A -15.19% Oncology Institute -15.38%-445.02%-34.13% Do analysts rate LFMD or TOI? LifeMD presently has a consensus price target of $12.86, suggesting a potential upside of 14.18%. Oncology Institute has a consensus price target of $7.00, suggesting a potential upside of 123.64%. Given Oncology Institute's higher probable upside, analysts clearly believe Oncology Institute is more favorable than LifeMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals hold more shares of LFMD or TOI? 35.5% of LifeMD shares are held by institutional investors. Comparatively, 36.9% of Oncology Institute shares are held by institutional investors. 18.4% of LifeMD shares are held by company insiders. Comparatively, 8.5% of Oncology Institute shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, LFMD or TOI? LifeMD has a beta of 2.4, indicating that its stock price is 140% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500. SummaryLifeMD beats Oncology Institute on 11 of the 14 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$256.10M$7.31B$5.61B$9.11BDividend YieldN/A2.81%5.24%4.01%P/E RatioN/A22.3519.7619.92Price / Sales0.7135.55430.8999.65Price / CashN/A23.3737.4658.16Price / Book62.606.858.045.49Net Income-$64.66M$230.16M$3.18B$250.27M7 Day Performance26.98%0.01%3.72%4.78%1 Month Performance9.44%-0.56%3.72%7.20%1 Year Performance578.96%36.33%29.92%17.27% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute1.7935 of 5 stars$3.13+9.1%$7.00+123.6%+517.1%$256.10M$393.41M-4.47660Positive NewsHigh Trading VolumeLFMDLifeMD1.6976 of 5 stars$13.62-0.9%$12.00-11.9%+105.5%$624.91M$212.45M-40.06230Analyst ForecastGap UpFLGTFulgent Genetics3.5895 of 5 stars$19.88+1.0%$24.00+20.7%-0.3%$599.13M$283.47M-14.951,313CSTLCastle Biosciences2.3463 of 5 stars$20.42+0.3%$37.00+81.2%+13.5%$587.55M$332.07M-107.47540PSNLPersonalis3.4884 of 5 stars$6.56-0.3%$7.67+16.9%+346.5%$581.18M$85.69M-5.09400News CoverageINNVInnovAge1.0827 of 5 stars$3.69-5.9%$5.00+35.5%-16.2%$529.25M$763.85M-16.042,350News CoverageGap DownEHABEnhabit2.5127 of 5 stars$9.64+0.8%$8.75-9.2%-14.2%$484.09M$1.03B-3.4810,700Positive NewsSBCSBC Medical GroupN/A$4.64flatN/AN/A$480.76M$205.42M0.00N/AHigh Trading VolumeCELCCelcuity2.2969 of 5 stars$13.35+6.5%$30.80+130.7%-19.2%$474.84MN/A-4.4140Positive NewsAUNAAuna3.3206 of 5 stars$6.20-2.2%$10.70+72.6%-19.2%$469.24M$1.17B10.6914,842High Trading VolumeTALKTalkspace3.9329 of 5 stars$2.78+0.4%$4.50+61.9%+36.8%$463.46M$187.59M139.07500News CoveragePositive News Related Companies and Tools Related Companies LifeMD Alternatives Fulgent Genetics Alternatives Castle Biosciences Alternatives Personalis Alternatives InnovAge Alternatives Enhabit Alternatives SBC Medical Group Alternatives Celcuity Alternatives Auna Alternatives Talkspace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TOI Stock Alerts